Trial Milestones. Covad shall notify BA of its request for a Technical and/or Operational Trial in writing and share any technical information pertinent to such trial concerning potential interference issues. Covad will provide BA with a list of proposed locations for said trial(s). BA will indicate a suitable location from such list for said trial within 15 business days of receipt of Covad’s list. In the event Covad does not have a suitable Collocation space at the designated trial location, it shall submit a Collocation Application within 30 business days of the trial request. The Parties shall then meet to agree upon a Trial Plan for the requested trial(s). The Trial Plan shall include, but is not limited to, the minimum and maximum volumes for each Local Loop type (which shall be in the range of 10 to 20 loops), the trial location, the technical and/or operational trial paramenters and expected results for the specified Technical and/or Operational trial. The Trial Plan shall be a joint work effort completed no later than the completion of Collocation space to be used in the trial, if ordered, or 120 days from the trial request, whichever is later, or as otherwise mutually agreed. Covad shall provide BA with fourteen (14) days written prior notice of its Equipment Ready Date (ERD). Such notice shall indicate the date upon which Covad can and will accept termination of and turn-up of the trial Local Loop(s). The Technical Trial shall commence no later than 10 business days from the ERD and shall be of a duration of not more than 60 days. The Operational Trial shall commence the later of 30 days from the ERD or September 1, 1998 and shall be of a duration of not more than 60 days. Upon successful completion as defined in the Trial Plan of the Technical Trial, if necessary, and Operational Trial, which includes, but is not limited to, the resolution of any network interference or other network impairment issues, the Parties shall agree upon an implementation schedule for deployment of the ULL type(s) subject to such trial(s). Within 60 days of successful completion of the Operational Trial as defined in the Trial Plan, BA will publish relevant documentation. At that time, Covad may order and use the type of ULL which had been the subject of the trial in conformance with the BA published references and guidelines for such ULL type.
Trial Milestones. 7.1 Institution and Principal Investigator will use their best endeavors to enroll Institution’s Enrollment Maximum of Trial Subjects before the Target Enrollment End Date. Sponsor may at any time reduce the Institution’s Enrollment Maximum or end enrollment at Institution at Sponsor’s discretion. Sponsor through CRO will not be obligated to make any payment with respect to any subject enrolled in excess of the Institution’s Enrollment Maximum. 7.2 All Trial Subject visits will be completed no later than the Target Visits Completed Date. All CRF information associated with a Trial Subject's visit must be satisfactorily completed within seven (7) calendar days after the Trial Subject's visit or, if applicable, receipt of the Trial Subject's test results. All final CRF data will be entered into the CRF and submitted to CRO/Sponsor no later than five (5) calendar days after the Trial Subject’s final visit or, if applicable, receipt of the subject’s final test results. All data queries from Sponsor/CRO must be completed and returned to Sponsor/CRO within seven (7) calendar days or, if during final clean up, one (1) business day, or such other time set by Sponsor/CRO. In all instances described in this section, time is of the essence. 7.3 “Target” as used above means projected Trial milestones subject to change by Sponsor. Any update to such Target dates will be communicated to Institution and Principal Investigator without the necessity of modifying this Agreement. zákonného požadavku. Uzavření této smlouvy slouží jako souhlas hlavního zkoušejícího se shromažďováním, zpracováváním a zveřejňováním údajů uvedených v této smlouvě pro zmíněné účely. 7. Klíčová stadia klinického hodnocení. 7.1 Zdravotnické zařízení a hlavní zkoušející vynaloží maximální úsilí, aby před cílovým datem ukončení zařazování stihli zařadit maximální počet zařazených subjektů klinického hodnocení zdravotnickým zařízením. Zadavatel může dle vlastního uvážení kdykoli ve zdravotnickém zařízení omezit maximální počet zařazených subjektů klinického hodnocení zdravotnickým zařízením nebo omezit ukončení zařazování. Zadavatel není povinen prostřednictvím společnosti CRO provést žádnou platbu pro subjekt klinického hodnocení zapsaný nad rámec maximálního počtu zařazených subjektů klinického hodnocení zdravotnickým zařízením. 7.2 Veškeré návštěvy subjektů klinického hodnocení musí být dokončeny před cílovým datem dokončených návštěv. Veškeré údaje z CRF spojené s návštěvou subjektu klinického hodn...
